fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Lung Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eger, EI; Ferrell, LD; Gonsowski, CT; Kerschmann, RL; Laster, MJ | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Lung Diseases
Article | Year |
---|---|
Toxicity of compound A in rats. Effect of increasing duration of administration.
Topics: Anesthetics; Animals; Body Weight; Cell Division; Dose-Response Relationship, Drug; Drug Administration Schedule; Ethers; Hydrocarbons, Fluorinated; Immunohistochemistry; Kidney Diseases; Lethal Dose 50; Lung Diseases; Male; Methyl Ethers; Nuclear Proteins; Proliferating Cell Nuclear Antigen; Pulmonary Edema; Rats; Rats, Wistar; Regeneration; Sevoflurane; Time Factors | 1994 |